Assoicated Medical Conditions for Celiac Disease

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteris in To
Acne 26.3 % 5 19 67
ADHD 17 % 8 47 67
Allergies 16 % 8 50 67
Alzheimer's disease 18 % 9 50 67
Amyotrophic lateral sclerosis (ALS) Motor Neuron 18.6 % 8 43 67
Ankylosing spondylitis 31.3 % 21 520 67
Asthma 25.9 % 7 27 67
Atherosclerosis 25.4 % 17 524 67
Autism 35.8 % 24 110 67
Barrett esophagus cancer 18.8 % 3 16 67
Bipolar Disorder 15.2 % 5 33 67
Brain Trauma 18.2 % 4 22 67
Carcinoma 31.4 % 16 51 67
Cerebral Palsy 35.3 % 6 17 67
Chronic Fatigue Syndrome 10.9 % 6 55 67
Chronic Kidney Disease 20 % 7 35 67
Chronic Urticaria (Hives) 26.1 % 6 23 67
Colorectal Cancer 17.9 % 12 296 67
Coronary artery disease 25 % 4 16 67
COVID-19 25 % 9 36 67
Crohn's Disease 37.3 % 25 141 67
Depression 16.4 % 11 81 67
Epilepsy 28 % 7 25 67
Fibromyalgia 10.8 % 4 37 67
Functional constipation / chronic idiopathic constipation 12.2 % 5 41 67
gallstone disease (gsd) 20 % 3 15 67
Generalized anxiety disorder 21.4 % 3 14 67
Graves' disease 12.5 % 1 8 67
Hashimoto's thyroiditis 21.4 % 3 14 67
High Blood Pressure 21.3 % 10 47 67
hypercholesterolemia (High Cholesterol) 11.1 % 1 9 67
Hyperlipidemia (High Blood Fats) 24 % 6 25 67
IgA nephropathy (IgAN) 20.7 % 6 29 67
Inflammatory Bowel Disease 19.7 % 13 66 67
Insomnia 40 % 4 10 67
Irritable Bowel Syndrome 21 % 13 62 67
Liver Cirrhosis 46.3 % 31 678 67
ME/CFS with IBS 15.8 % 3 19 67
ME/CFS without IBS 15.4 % 4 26 67
Metabolic Syndrome 57.1 % 4 7 67
Mood Disorders 16.7 % 1 6 67
Multiple Sclerosis 19.4 % 13 100 67
Multiple system atrophy (MSA) 23.8 % 5 21 67
neuropsychiatric disorders (PANDAS, PANS) 33.3 % 5 15 67
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 19.4 % 13 76 67
Obesity 25.4 % 17 104 67
Obesity 21.8 % 12 55 67
Osteoporosis 27.3 % 6 22 67
Parkinson's Disease 14.9 % 10 90 67
Psoriasis 13 % 6 46 67
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 25.4 % 17 134 67
Schizophrenia 17.9 % 12 93 67
Sjögren syndrome 31.7 % 13 41 67
Small Intestinal Bacterial Overgrowth (SIBO) 31.3 % 5 16 67
Stress / posttraumatic stress disorder 14.3 % 8 56 67
Systemic Lupus Erythematosus 21.2 % 14 66 67
Type 1 Diabetes 19.2 % 10 52 67
Type 2 Diabetes 53.7 % 36 267 67
Ulcerative colitis 31.3 % 21 108 67

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.